+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID06487286

Study of Visfatin Levels in Human Milk and Their Relation to Newborn Health and Weight

Led by Paolo Manzoni Study Group · Updated on 2024-11-14

30

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the levels of Visfatin, a substance found in maternal milk, to understand its relationship with newborn conditions, especially newborn weight loss. The study focuses on measuring Visfatin concentrations in mothers during the postpartum period to explore its potential as a biomarker for predicting newborn health outcomes. This observational study involves collecting maternal milk samples at three specific times after birth 48 hours, 7 days, and 30 days. Additionally, Visfatin levels in maternal plasma or serum will be measured 1 to 2 days after delivery. The study also plans to analyze correlations between Visfatin levels and biological or clinical features of both mothers and newborns. Participants will provide milk and blood samples at the specified time points. Researchers will use an ELISA kit to analyze Visfatin levels across these samples. The study will track how these levels change over time and relate to newborn health and weight. This information aims to improve understanding of newborn weight changes and maternal factors. The study will continue to monitor Visfatin values up to 6 months after birth.

CONDITIONS

Brief Title

Levels of Visfatin/NAMPT in Human Milk

Research Team

P

Paolo Manzoni, Professor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here